Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diuretics vs alpha-blockers for treatment of hypertension: lessons from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

× No keyword cloud information.

11 in total

Review 1. Concentration-controlled or effect-controlled trials: useful alternatives to conventional dose-controlled trials?

Authors: A Grahnén; M O Karlsson
Journal: Clin Pharmacokinet Date: 2001 Impact factor: 6.447

Review 2. Recent clinical trial highlights in hypertension.

Authors: F C Luft
Journal: Curr Hypertens Rep Date: 2001-04 Impact factor: 5.369

3. Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk.

Authors: Gerald W Smetana
Journal: J Gen Intern Med Date: 2012-06 Impact factor: 5.128

Review 4. Telmisartan: a review of its use in hypertension.

Authors: M Sharpe; B Jarvis; K L Goa
Journal: Drugs Date: 2001 Impact factor: 9.546

Review 5. Diastolic heart failure in the elderly.

Authors: Dalane W Kitzman
Journal: Heart Fail Rev Date: 2002-01 Impact factor: 4.214

Review 6. Doxazosin gastrointestinal therapeutic system: a review of its use in benign prostatic hyperplasia.

Authors: David R Goldsmith; Greg L Plosker
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 7. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.

Authors: Ezequiel Balmori Melian; Blair Jarvis
Journal: Drugs Date: 2002 Impact factor: 9.546

8. The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress.

Authors: René R Wenzel; Anna Mitchell; Winfried Siffert; Sandra Bührmann; Thomas Philipp; Rafael F Schäfers
Journal: Br J Clin Pharmacol Date: 2004-05 Impact factor: 4.335

9. Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure.

Authors: D Gregg Rokosh; Paul C Simpson
Journal: Proc Natl Acad Sci U S A Date: 2002-07-01 Impact factor: 11.205

10. Diastolic Dysfunction.

Authors: Sean W. Murphy
Journal: Curr Treat Options Cardiovasc Med Date: 2004-02